maria luz calibo
Sep 24, 2011

Isis Pharma files patent suit against Santaris

Isis Pharmaceuticals Inc. said Friday it has filed a patent infringement lawsuit against Santaris Pharma A/S and Santaris Pharma A/S Corp. Isis filed the suit in the U.S. District Court of the Southern District of California, the company said in a statement. Isis says in the suit that Santaris has infringed on patents for Isis' gene-blocking antisense technology, which stops production of disease-causing proteins by selectively suppressing...